Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20061821 | 0.89 | KDM4E (0.31) | KDM4E | |
| SCHEMBL20061823 | 0.89 | KDM4E (0.33) | KDM4E | |
| SCHEMBL20061800 | 0.89 | KDM4E (0.31) | KDM4E | |
| SCHEMBL20061789 | 0.88 | KDM4E (0.40) | EGFRKDM4E | |
| SCHEMBL20061794 | 0.87 | KDM4E (0.33) | KDM4E | |
| SCHEMBL20061784 | 0.84 | EGFR (0.38) | EGFRKDM4E | |
| SCHEMBL20061804 | 0.82 | EGFR (0.35) | EGFRKDM4E | |
| SCHEMBL20061819 | 0.80 | KDM4E (0.34) | KDM4E | |
| SCHEMBL20061791 | 0.79 | MAPK9 (0.37) | EGFRKDM4E | |
| SCHEMBL20061818 | 0.79 | MAPK9 (0.37) | EGFRKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11239432-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-02-01 | — | — | US | disclosed |
| US-20180108848-A1 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-04-19 | — | — | US | disclosed |
| US-20180108848-A1 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11239432-B2 | Organic electroluminescent materials and devices | OCIAD1, OSBP, OCIAD2 | EGFR 3000/4885KDM4E 4450/4885 |
| US-20180108848-A1 | Organic electroluminescent materials and devices | OSBP, OSBP2, OCIAD2 | EGFR 4403/4885KDM4E 4668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.